Practice and challenges of thorough QT studies

被引:18
|
作者
Stockbridge, Norman [3 ]
Zhang, Joanne [4 ]
Garnett, Christine [5 ]
Malik, Marek [1 ,2 ]
机构
[1] St Pauls Cardiac Electrophysiol, London, England
[2] Univ London, London, England
[3] US FDA, Div Cardiovasc & Renal Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[4] US FDA, Div Biometr 6, Off Biostat, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[5] US FDA, Div Pharmacometr, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD USA
关键词
QT interval; Torsade de pointes tachycardia; Drug safety; TORSADE-DE-POINTES; PHARMACODYNAMIC-ANALYSIS; PHARMACOKINETICS; PROLONGATION; MOXIFLOXACIN; DISOPYRAMIDE; QUINIDINE; INTERVAL; DESIGN; MODEL;
D O I
10.1016/j.jelectrocard.2012.07.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The drug-induced Torsade de Pointes (TdP) tachycardia is a known regulatory problem which led to the concept of the so-called thorough QT (TQT) studies now required for practically every new pharmaceutical compound. This review summarizes the concept of the TQT studies, their statistical evaluation, and related pharmacodynamic /pharmacokinetic modeling. The review also lists suggestions of how to make TQT studies more efficient and how to improve the interpretation of clinical data obtained during drug development to identify drugs prone to TdP induction more effectively. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:582 / 587
页数:6
相关论文
共 50 条
  • [21] Alternative Methods For The Confirmation Of Assay Sensitivity In Thorough QT Studies
    Taubel, Jorg
    Naseem, Asif
    Ferber, Georg
    Camm, Alan J.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1359 - 1359
  • [22] The effect of moxifloxacin on QTc and implications for the design of thorough QT studies
    Bloomfield, D. M.
    Kost, J. T.
    Ghosh, K.
    Hreniuk, D.
    Hickey, L. A.
    Guitierrez, M. J.
    Gottesdiener, K.
    Wagner, J. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (04) : 475 - 480
  • [23] Exposure-Response Modeling Approach for Assessing QT Effect in Thorough QT/QTc Studies
    Hosmane, Balakrishna
    Locke, Charles
    Chiu, Yi-Lin
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (03) : 624 - 640
  • [24] Thorough QT StudiesQuestions and Quandaries
    Marek Malik
    Christine E. Garnett
    Joanne Zhang
    [J]. Drug Safety, 2010, 33 : 1 - 14
  • [25] A thorough QT study of guanfacine
    Martin, Patrick
    Satin, Lawrence
    Kahn, Robert S.
    Robinson, Antoine
    Corcoran, Mary
    Purkayastha, Jaideep
    Youcha, Sharon
    Ermer, James C.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (04) : 301 - 316
  • [26] Design of the "Thorough QT Study''
    Darpo, B.
    Sager, P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (04) : 528 - 529
  • [27] A Comparison of Several Methods For Analyzing Data from Thorough QT Studies
    Tian, Hong
    Qiao, Wenqian
    Natarajan, Jaya
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (03) : 604 - 612
  • [28] A powerful test for the maximum treatment effect in thorough QT/QTc studies
    Deng, Yuhao
    Chen, Fangyi
    Li, Yang
    Qian, Kaihuan
    Wang, Rui
    Zhou, Xiao-Hua
    [J]. STATISTICS IN MEDICINE, 2021, 40 (08) : 1947 - 1959
  • [29] Comparisons of different concentration-response models in the thorough QT studies
    Luo, Huanyuan
    Taubel, Jorg
    Chen, Tao
    Wang, Duolao
    [J]. TRIALS, 2019, 20
  • [30] Comparison of Two Methods of Estimating Reader Variability in QT Interval Measurements in Thorough QT/QTc Studies
    Salvi, Vaibhav
    Karnad, Dilip R.
    Kerkar, Vaibhav
    Panicker, Gopi Krishna
    Natekar, Mili
    Kothari, Snehal
    [J]. ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2014, 19 (02) : 182 - 189